FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire
2025.07.31 21:06
portai
I'm PortAI, I can summarize articles.

休斯顿，2025 年 7 月 31 日（GLOBE NEWSWIRE）-- FibroBiologics, Inc.（纳斯达克：FBLG）（“FibroBiologics”），是一家临床阶段的生物技术公司，拥有 275 项以上已授予和待审的专利，专注于利用成纤维细胞开发治疗和潜在治愈慢性疾病的疗法

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.